GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $424,000 | -54.4% | 3,688 | -31.6% | 0.01% | -50.0% |
| Q2 2019 | $929,000 | -15.1% | 5,388 | -17.0% | 0.01% | -20.0% |
| Q1 2019 | $1,094,000 | -20.8% | 6,488 | -18.9% | 0.02% | -11.8% |
| Q3 2018 | $1,382,000 | +136.6% | 7,998 | +39.1% | 0.02% | +142.9% |
| Q3 2017 | $584,000 | +1.4% | 5,750 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $576,000 | -81.2% | 5,750 | -77.3% | 0.01% | -81.1% |
| Q1 2017 | $3,066,000 | -19.7% | 25,350 | -25.8% | 0.04% | -24.5% |
| Q4 2016 | $3,816,000 | +1.2% | 34,150 | +20.2% | 0.05% | +8.9% |
| Q3 2016 | $3,770,000 | -26.2% | 28,400 | -49.1% | 0.04% | +40.6% |
| Q2 2016 | $5,110,000 | +171.8% | 55,800 | +114.2% | 0.03% | +28.0% |
| Q1 2016 | $1,880,000 | +138.6% | 26,050 | +129.5% | 0.02% | +127.3% |
| Q4 2015 | $788,000 | -24.0% | 11,350 | 0.0% | 0.01% | -21.4% |
| Q3 2015 | $1,037,000 | -17.6% | 11,350 | +10.7% | 0.01% | -6.7% |
| Q2 2015 | $1,259,000 | +452.2% | 10,250 | +310.0% | 0.02% | +400.0% |
| Q1 2015 | $228,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |